Wai Yuen Tong Medicine Holdings Limited (HKG:0897)
Hong Kong · Delayed Price · Currency is HKD 0.3550
0.00 (0.00%)
At close: Feb 13, 2026
HKG:0897 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 721.27 | 745.3 | 783.88 | 723.6 | 1,391 | 1,109 | |
Revenue Growth (YoY) | -6.71% | -4.92% | 8.33% | -47.99% | 25.52% | 78.59% |
Cost of Revenue | 361.54 | 368.85 | 389.07 | 381.24 | 817.26 | 666.63 |
Gross Profit | 359.73 | 376.45 | 394.81 | 342.36 | 574.15 | 441.93 |
Selling, General & Admin | 398.66 | 408.3 | 354.98 | 331.52 | 499.2 | 429.26 |
Operating Expenses | 411.77 | 423.36 | 353.93 | 337.37 | 504.58 | 428.1 |
Operating Income | -52.04 | -46.91 | 40.88 | 4.99 | 69.58 | 13.83 |
Interest Expense | -22.05 | -28.16 | -40.79 | -29.51 | -95.7 | -107.72 |
Interest & Investment Income | 40.9 | 46.21 | 48.24 | 47.13 | 25.35 | 29.66 |
Earnings From Equity Investments | 0.71 | 1.05 | 2.53 | 2.95 | 1.57 | 4.65 |
Currency Exchange Gain (Loss) | -0.97 | -0.5 | -2.63 | -3.71 | 6.97 | 2.07 |
Other Non Operating Income (Expenses) | 5.61 | 5.83 | 7.91 | 5.06 | 55.29 | 72.57 |
EBT Excluding Unusual Items | -27.85 | -22.47 | 56.14 | 26.92 | 63.06 | 15.06 |
Gain (Loss) on Sale of Investments | -0.09 | -4.84 | -12.83 | -11.6 | -78.07 | -232 |
Gain (Loss) on Sale of Assets | 0.27 | 15.17 | 29.5 | -1.48 | 1.81 | -0.24 |
Asset Writedown | 7.46 | 14.2 | -86.48 | -20.13 | -80.62 | -56.95 |
Legal Settlements | - | - | - | - | 48.57 | - |
Other Unusual Items | 1.67 | 2.01 | 0.04 | 0.39 | -2.06 | -29.01 |
Pretax Income | -18.54 | 4.08 | -13.63 | -5.91 | -47.3 | -303.13 |
Income Tax Expense | -4.69 | -3.02 | -6.36 | -13.32 | 40.52 | 148.13 |
Earnings From Continuing Operations | -13.85 | 7.09 | -7.27 | 7.41 | -87.82 | -451.26 |
Earnings From Discontinued Operations | - | - | 11.32 | -4.07 | - | - |
Net Income to Company | -13.85 | 7.09 | 4.05 | 3.35 | -87.82 | -451.26 |
Minority Interest in Earnings | 0.02 | 0.01 | -19.4 | -23.86 | -21.09 | 75.27 |
Net Income | -13.83 | 7.1 | -15.36 | -20.52 | -108.91 | -376 |
Net Income to Common | -13.83 | 7.1 | -15.36 | -20.52 | -108.91 | -376 |
Shares Outstanding (Basic) | 1,125 | 1,126 | 1,181 | 1,216 | 1,232 | 1,232 |
Shares Outstanding (Diluted) | 1,125 | 1,126 | 1,181 | 1,216 | 1,232 | 1,232 |
Shares Change (YoY) | -3.43% | -4.70% | -2.87% | -1.25% | - | - |
EPS (Basic) | -0.01 | 0.01 | -0.01 | -0.02 | -0.09 | -0.31 |
EPS (Diluted) | -0.01 | 0.01 | -0.01 | -0.02 | -0.09 | -0.31 |
Free Cash Flow | 83.89 | 75.16 | 157.04 | 134.89 | 143.07 | 353.05 |
Free Cash Flow Per Share | 0.07 | 0.07 | 0.13 | 0.11 | 0.12 | 0.29 |
Dividend Per Share | - | - | 0.030 | - | - | - |
Gross Margin | 49.87% | 50.51% | 50.37% | 47.31% | 41.26% | 39.87% |
Operating Margin | -7.22% | -6.29% | 5.21% | 0.69% | 5.00% | 1.25% |
Profit Margin | -1.92% | 0.95% | -1.96% | -2.83% | -7.83% | -33.92% |
Free Cash Flow Margin | 11.63% | 10.08% | 20.03% | 18.64% | 10.28% | 31.85% |
EBITDA | -19.22 | -13.56 | 92.58 | 59.6 | 130.58 | 72.83 |
EBITDA Margin | -2.67% | -1.82% | 11.81% | 8.24% | 9.38% | 6.57% |
D&A For EBITDA | 32.82 | 33.35 | 51.7 | 54.61 | 61 | 59 |
EBIT | -52.04 | -46.91 | 40.88 | 4.99 | 69.58 | 13.83 |
EBIT Margin | -7.22% | -6.29% | 5.21% | 0.69% | 5.00% | 1.25% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.